Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Prevention of Atrial Fibrillation After Cardiac Surgery
NCT02099331Phase 2Withdrawn
- Sponsor
- Johns Hopkins University
- Start
- Sep 2014
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melatonin in Atrial fibrillation (AFib), sponsored by Johns Hopkins University. Planned start Sep 2014; status: withdrawn.
02
Drugs
melatonin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02099331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02099331.